Literature DB >> 11751716

Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery.

N Gokce1, M Holbrook, S J Duffy, S Demissie, L A Cupples, E Biegelsen, J F Keaney, J Loscalzo, J A Vita.   

Abstract

Black Americans have increased morbidity and mortality rates from cardiovascular disease, greater prevalence of hypertension, and altered responses to vasodilator medications compared with those of white Americans. Hypertension and black race have been linked to impaired vascular function in the microcirculation. To examine these effects and their interaction in the conduit vasculature, we examined vasomotor responses of the brachial artery by using high-resolution vascular ultrasound in 228 subjects (48% hypertensive, 54% black). Subjects had no history of diabetes mellitus and were matched for age and gender. Flow-mediated dilation (8.5+/-5.3% versus 11.7+/-6.3%, P<0.001) and nitroglycerin-mediated vasodilation (14.9+/-6.0 versus 18.5+/-7.8, P=0.003) were both impaired in hypertensive compared with normotensive individuals. Multivariate analysis identified higher systolic blood pressure (P=0.003) and larger baseline vessel (P<0.001) size as independent predictors of lower flow-mediated dilation. Race did not significantly influence flow-mediated dilation. In contrast, blacks had a greater vasodilator response to nitroglycerin compared with whites (17.7+/-7.5% versus 15.0+/-6.2%, respectively; P=0.02). By multivariate analysis, black race (P=0.004), smaller vessel size (P=0.001), lower serum glucose (P=0.02), lower systolic blood pressure (P=0.02), and lower serum total cholesterol (P=0.04) were independent predictors of higher nitroglycerin-mediated dilation. Thus, hypertension is associated with impaired NO-mediated vasodilation in the conduit brachial artery. Overall, race did not influence flow-mediated dilation, but black race was associated with an enhanced response to sublingual nitroglycerin. This later observation provides further evidence of racial differences in the responses to medical therapy that may be relevant to the treatment of patients with cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751716     DOI: 10.1161/hy1201.096575

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  Endothelial function and outdoor temperature.

Authors:  Tim S Nawrot; Jan A Staessen; Robert H Fagard; Luc M Van Bortel; Harry A Struijker-Boudier
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Racial differences in nitric oxide-dependent vasorelaxation.

Authors:  Eugenia Mata-Greenwood; Dong-Bao Chen
Journal:  Reprod Sci       Date:  2008-01       Impact factor: 3.060

3.  Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.

Authors:  Isaac J Powell; Cathryn H Bock; Julie J Ruterbusch; Wael Sakr
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

Review 4.  The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.

Authors:  Isaac J Powell
Journal:  Arch Esp Urol       Date:  2011-10       Impact factor: 0.436

5.  Endothelial function in HIV-infected persons.

Authors:  Anthony Solages; Joseph A Vita; David J Thornton; Jessica Murray; Timothy Heeren; Donald E Craven; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2006-03-31       Impact factor: 9.079

6.  Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea.

Authors:  Patricia K Nguyen; Chandra K Katikireddy; Michael V McConnell; Clete Kushida; Phillip C Yang
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-03       Impact factor: 5.364

7.  Predictors of improvement in endothelial function after exercise training in a diverse sample of postmenopausal women.

Authors:  Damon L Swift; Judith Y Weltman; James T Patrie; Susan A Saliba; Glenn A Gaesser; Eugene J Barrett; Arthur Weltman
Journal:  J Womens Health (Larchmt)       Date:  2013-12-03       Impact factor: 2.681

8.  Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.

Authors:  David Conen; Robert J Glynn; Julie E Buring; Paul M Ridker; Robert Y L Zee
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

Review 9.  Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype.

Authors:  Jaume Padilla; Nathan T Jenkins; M Harold Laughlin; Paul J Fadel
Journal:  Eur J Appl Physiol       Date:  2013-07-17       Impact factor: 3.078

10.  Reduction in blood pressure improves impaired nitroglycerine-induced vasodilation in patients with essential hypertension.

Authors:  Tatsuya Maruhashi; Ayumu Nakashima; Shinji Kishimoto; Akimichi Iwamoto; Masato Kajikawa; Nozomu Oda; Yasuki Kihara; Yoshiki Aibara; Kensuke Noma; Yukihito Higashi
Journal:  Hypertens Res       Date:  2015-09-03       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.